Durable Schistosome induced metabolic alterations to the myeloid lineage

持久的血吸虫诱导骨髓谱系的代谢改变

基本信息

  • 批准号:
    10559643
  • 负责人:
  • 金额:
    $ 55.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-05 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Diabetic patients have a two-fold greater risk of developing cardiovascular disease than non-diabetic subjects, and more than 65% of diabetic patients die from cardiovascular complications, thus, there is a critical need for novel approaches to targeting insulin resistance, obesity, and atherosclerosis in this population. Recent evidence has suggested that innate and/or adaptive inflammatory responses are associated with both insulin resistance and obesity, while atherosclerosis is now widely accepted to be a lipid-dependent chronic inflammatory disease. An increasing body of literature has established an inverse correlation between chronic helminth infections and metabolic syndrome/diabetes. The central hypothesis of this project is that schistosome antigenic exposure induces long-lived modifications in the monocyte/macrophage lineage that lead to profound alterations in systemic phospholipid, cholesterol, and amino acid metabolism, resulting in a protective state from the detrimental effects of High Fat Diet (HFD) (e.g., insulin insensitivity, and atherosclerosis). The rationale for this research is that identifying genetic drivers that underlie this protective phenotype is expected to enable the formulation and development of therapies to target these pathways as treatments for diabetic patients at risk for CVD. This objective will be addressed by pursuing three specific aims: 1) Define the role of S. mansoni infection in regulating the long-term metabolic and immunological function of macrophages; 2) Determine how S. mansoni infection regulates hematopoietic differentiation of macrophages at the transcriptional level; and 3) Determine the role of biological sex and sex hormones in schistosome induced metabolic reprogramming. It is expected that the findings from these studies will provide a definitive conceptual framework as to the mechanism through which S. mansoni infection modulates metabolism and immunologic plasticity of the macrophage lineage.
项目概要 糖尿病患者患心血管疾病的风险是非糖尿病患者的两倍, 超过65%的糖尿病患者死于心血管并发症,因此迫切需要 针对该人群的胰岛素抵抗、肥胖和动脉粥样硬化的新方法。最近的 有证据表明先天性和/或适应性炎症反应与胰岛素相关 抵抗力和肥胖,而动脉粥样硬化现在被广泛认为是一种脂质依赖性慢性病 炎症性疾病。越来越多的文献已经证实慢性病之间存在负相关关系。 蠕虫感染和代谢综合征/糖尿病。该项目的中心假设是 血吸虫抗原暴露会引起单核细胞/巨噬细胞谱系的长期改变, 导致全身磷脂、胆固醇和氨基酸代谢发生深刻改变,从而导致 免受高脂肪饮食 (HFD) 有害影响的保护状态(例如胰岛素不敏感和 动脉粥样硬化)。这项研究的基本原理是确定这种保护作用背后的遗传驱动因素 表型有望使针对这些途径的疗法的制定和开发成为可能 对有心血管疾病风险的糖尿病患者进行治疗。这一目标将通过追求三个具体目标来实现 目标:1)明确曼氏沙门氏菌感染在调节长期代谢和免疫学方面的作用 巨噬细胞的功能; 2) 确定曼氏沙门氏菌感染如何调节造血分化 转录水平的巨噬细胞; 3) 确定生物性别和性激素在 血吸虫诱导代谢重编程。预计这些研究的结果将提供 关于曼氏沙门氏菌感染调节机制的明确概念框架 巨噬细胞谱系的代谢和免疫可塑性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eyal Amiel其他文献

Eyal Amiel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eyal Amiel', 18)}}的其他基金

Durable Schistosome induced metabolic alterations to the myeloid lineage
持久的血吸虫诱导骨髓谱系的代谢改变
  • 批准号:
    10184936
  • 财政年份:
    2021
  • 资助金额:
    $ 55.6万
  • 项目类别:
Durable Schistosome induced metabolic alterations to the myeloid lineage
持久的血吸虫诱导骨髓谱系的代谢改变
  • 批准号:
    10366064
  • 财政年份:
    2021
  • 资助金额:
    $ 55.6万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 55.6万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 55.6万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 55.6万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 55.6万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 55.6万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 55.6万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 55.6万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 55.6万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 55.6万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 55.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了